Physician profile
Charmaine E Edwards
NPI 1972586253
$6,062.95
in general payments reported to CMS, 2019-2025
20 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.78 · 2021: $715 · 2022: $1,153 · 2023: $1,129 · 2024: $1,574 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,956 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,955.51 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,491.67 | 2021-2025 | Rinvoq, Skyrizi, Mavyret |
| Genzyme Corporation | $924.93 | 2022-2025 | |
| Janssen Biotech, INC. | $846.66 | 2022-2025 | Stelara, Tremfya |
| Pfizer INC. | $701.95 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.22 | 2021-2022 | |
| Qol Medical, LLC | $171.72 | 2021-2025 | Sucraid, Sucraid |
| Boston Scientific Corporation | $137.77 | 2025 | Exalt Model D |
| Ardelyx, INC. | $133.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $105.08 | 2021 | |
| Phathom Pharmaceuticals, INC. | $51.78 | 2025 | Voquezna |
| Gilead Sciences, INC. | $49.87 | 2019-2025 | |
| Celgene Corporation | $49.86 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.59 | 2022-2025 | Eohilia |
| Braintree Laboratories, INC. | $35.85 | 2023 | Sutab, Suflave |
| Ironwood Pharmaceuticals, INC | $26.30 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.50 | 2022 | |
| Exact Sciences Corporation | $17.72 | 2025 | The Cologuard Plus Collection Kit |
| Intercept Pharmaceuticals, INC. | $16.10 | 2024 | |
| Novo Nordisk INC | $12.73 | 2019 | |
| Allergan, INC. | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charmaine Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.